<?xml version="1.0" encoding="UTF-8"?>
<p>Emboldened by the entry of DAA regimens, the World Health Organization (WHO) and member states initiated in 2016 the Global Health Sector Strategy (GHSS) for Viral Hepatitis to eliminate HCV by 2030, with a focus on low and middle-income countries (LMICs) [
 <xref rid="B5-ijerph-17-04951" ref-type="bibr">5</xref>]. The GHSS’s First Strategic Direction aims to increase information for focused action (identifying hepatitis epidemics and the target populations to treat), and the Second and Fourth Strategic Directions focus on defining high-impact interventions and increasing these interventions’ cost-effectiveness to promote sustainability, respectively [
 <xref rid="B5-ijerph-17-04951" ref-type="bibr">5</xref>]. Despite the shared global aim of elimination, funding and aid given to these LMICs have declined, resulting in decreased funding for new and existing health programs.
</p>
